Case of Early-onset Dementia with Lewy Bodies Associated with PRKN Gene Mutation
Main Article Content
Abstract
Dementia with Lewy bodies is the second most common neurodegenerative form of dementia following Alzheimer’s disease, affecting 0.4% of people over the age of 65 every year. It is more commonly diagnosed in men than in women, and typically over the age of 50. It is a synucleinopathy, in which alpha-synuclein inclusions accumulate in neurons, similar to idiopathic Parkinson’s disease and multiple system atrophy. Clinical features include cognitive decline, bradykinetic movements, and visual hallucinations. Neuroimaging in dementia with Lewy bodies typically reveals occipital and parietal lobe atrophy and hypometabolism. Some cases of dementia with Lewy bodies and idiopathic Parkinson’s disease have been shown to be associated with genetic mutations, such as in the GBA gene. In this case report, we present a unique case of a young woman who started showing clinical features of dementia with Lewy bodies at the age of 44, with further confirmation of the diagnosis from neuroimaging studies. However, her genetic test results revealed the presence of a PRKN gene mutation, which has been described with Parkinson’s disease, even though she did not show typical clinical features of this disease. This report reveals a potential unique association of the PRKN mutation with early-onset dementia with Lewy bodies, indicating that we may have an incomplete understanding of the function of such genes in cognitive development, as well as the phenotypic presentations of dementia with Lewy bodies and Parkinson’s disease.
Article Details
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
2. Boot BP, McDade EM, McGinnis SM, et. al. Treatment of dementia with lewy bodies. Curr Treat Options Neurol. 2013 Dec;15(6):738-64.
3. Vann Jones SA, O’Brien JT. The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies. Psychol Med. 2014 Mar;44(4):673-83.
4. Savica R, Grossardt BR, Bower JH, et. al. Incidence of dementia with Lewy bodies and Parkinson disease dementia. JAMA Neurology. 2013 Nov; 70(11):1396-402.
5. Sim J, Li Huihua, Hameed S, et. al. Clinical Manifestations of Early-Onset Dementia With Lewy Bodies Compared With Late-Onset Dementia With Lewy Bodies and Early-Onset Alzheimer Disease. JAMA Neurol. 2022;79(7):702-709.
6. Stinton C, McKeith I, Taylor JP, et. al. Pharmacological Management of Lewy Body Dementia: A Systematic Review and Meta-Analysis. Am J Psychiatry. 2015 Aug 1;172(8):731-42.
7. Yousaf T, Dervenoulas G, Valkimadi PE, et. al. Neuroimaging in Lewy body dementia. J Neurol. 2019 Jan;266(1):1-26.
8. Gomperts SN. Lewy Body Dementias: Dementia With Lewy Bodies and Parkinson Disease Dementia. Continuum (Minneap Minn). 2016 Apr;22(2 Dementia):435-63.
9. Wakabayashi K, Tanji K, Odagiri S, et. al. The Lewy body in Parkinson’s disease and related neurodegenerative disorders. Mol Neurobiol. 2013 Apr;47(2):495-508.
10. Chia R, Sabir MS, Bandres-Ciga S, et. al. Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture. Nat Genet. 2021 Mar;53(3):294-303.
11. Clausen L, Okarmus J, Voutsinos V, et. al. PRKN-linked familial Parkinson's disease: cellular and molecular mechanisms of disease-linked variants. Cell Mol Life Sci. 2024 May 20;81(1):223.
12. Cherian A, Divya KP, Vijayaraghan A. Parkinson’s disease - genetic cause. Curr Opin Neurol. 2023 Aug 1;36(4):292-301.
13. 10. Daida K, Funayama M, Billingsley KJ, et. al. Long-Read Sequencing Resolves a Complex Structural Variant in PRKN Parkinson's Disease. Mov Disord. 2023 Dec;38(12):2249-2257.